Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
Treating method
Document Type and Number:
Japanese Patent JP5917143
Kind Code:
B2
Abstract:
The present invention relates generally to the methods for the treatment and diagnosis of conditions mediated by IL-5 and excess eosinophil production, and more specifically to mAbs, Fabs, chimeric and humanized antibodies. More particularly, the present invention relates generally to the treatment of eosinophilic bronchitis with an anti-IL-5 antibody or fragment thereof.

Inventors:
Fredrick, E. Hargreave
Jean Pietro, Bentlessca
Application Number:
JP2011502090A
Publication Date:
May 11, 2016
Filing Date:
March 27, 2009
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GlaxoSmithKline LLC
International Classes:
A61K39/395; A61K31/573; A61P1/00; A61P7/00; A61P7/10; A61P9/00; A61P11/00; A61P11/06; A61P17/00; A61P21/00; A61P33/10; A61P37/08
Other References:
BOLISH, L et al,J Allerg Clin Immunol,1996,Vol.77,No.3,p.719-733
VAN OOSTERHOUT A et al,Am Rev Resp Dis,1993,Vol.147,No.3,p.548-552
CHAND N et al,Eur J Pharmacol,1992,Vol.211,No.1,p.121-123
FLOOD-PAGE P et al,Am J Resp Crit Care,2007,Vol.176,p.1062-1071
ROTHENBERG M E et al,New England Journal of Medicine,2008 Mar,Vol.358,No.12,p.1215-1228
Pharma Medica,1998,Vol.16,No.5,p.35-45
金沢大学十全医学会雑誌,Vol.107,No.3,p.226-235
喘息,2003,Vol.16,No.2,p.77-81
メルクマニュアル第17版日本語版,1999,p.937-940
F.E. Hargreave et al,Clin Exp Allergy,2004,Vol.34,No.11,p.1807 ABSTRACT No.4
Attorney, Agent or Firm:
Hirohito Katsunuma
Hiroshi Sorimachi
Omori Miko